American Association for Cancer Research® (AACR) Annual Meeting 2026. Note that SciLeads is not affiliated with or endorsed by AACR.
We’re attending! As one of the most significant dates in the oncology calendar, this event brings together the brightest minds in cancer research to share groundbreaking discoveries and foster global collaboration. Taking place at the San Diego Convention Center in California from April 17–22, 2026, the meeting serves as a premier destination for anyone looking to stay at the cutting edge of life sciences and clinical practice.
The meeting covers a vast spectrum of cancer science, ranging from basic research and population science to clinical trials and survivorship. Key themes include immuno-oncology, genomics, precision medicine, and cancer prevention. This event is a “must-attend” for laboratory scientists, clinical investigators, and industry leaders looking to network with over 23,000 professional attendees and discover the latest tools and technologies driving the field forward.
About the meeting
The meeting is the focal point of the global cancer research community. It provides a comprehensive platform for scientists, clinicians, and patient advocates to share the latest advances in cancer medicine. The 2026 program features a high-impact agenda including plenary sessions on innovative technologies, “New Drugs on the Horizon” sessions, and extensive poster presentations showcasing over 6,000 proffered papers. Beyond the formal talks, attendees can participate in educational workshops, professional development forums, and vibrant networking events designed to bridge the gap between scientific discovery and real-world patient impact.
Key Details for the meeting
-
Location: San Diego Convention Center, 111 Harbor Drive, San Diego, CA 92101, USA
-
Dates: April 17 – April 22, 2026
Key Topics and Speakers for the meeting
-
Immuno-Oncology and Cellular Therapies: Harnessing the immune system for targeted treatment.
-
Genomics and Precision Medicine: Translating molecular insights into individualized patient care.
-
Cancer Prevention and Early Detection: Identifying new biomarkers and screening methods.
-
Tumor Biology and Microenvironment: Understanding the mechanics of cancer growth.
-
Experimental and Molecular Therapeutics: Highlighting the “New Drugs on the Horizon” sessions.
-
Regulatory Science and Policy: Open forums on FDA developments and clinical trial safety.
-
Science of Survivorship: Addressing long-term challenges for cancer survivors.
Who attends the meeting
-
Principal Investigators and Laboratory Scientists
-
Clinical Researchers and Oncologists
-
Translational Scientists
-
Bioinformaticians and Geneticists
-
Pharmaceutical and Biotech Industry Executives
-
Patient Advocates and Cancer Survivors
-
Postdoctoral Fellows and Graduate Students
-
Government and Regulatory Representatives (e.g., FDA, NCI)